HK74994A - EFA compositions and therapy - Google Patents
EFA compositions and therapyInfo
- Publication number
- HK74994A HK74994A HK74994A HK74994A HK74994A HK 74994 A HK74994 A HK 74994A HK 74994 A HK74994 A HK 74994A HK 74994 A HK74994 A HK 74994A HK 74994 A HK74994 A HK 74994A
- Authority
- HK
- Hong Kong
- Prior art keywords
- efa
- therapy
- compositions
- bioavailable
- dgla
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Medical Informatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909001121A GB9001121D0 (en) | 1990-01-18 | 1990-01-18 | Efa compositions and therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
HK74994A true HK74994A (en) | 1994-08-05 |
Family
ID=10669492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK74994A HK74994A (en) | 1990-01-18 | 1994-07-28 | EFA compositions and therapy |
Country Status (14)
Country | Link |
---|---|
US (1) | US5116624A (xx) |
EP (1) | EP0440341B1 (xx) |
JP (1) | JP3008213B2 (xx) |
AT (1) | ATE98125T1 (xx) |
AU (1) | AU638525B2 (xx) |
CA (1) | CA2033823C (xx) |
DE (1) | DE69100724T2 (xx) |
DK (1) | DK0440341T3 (xx) |
ES (1) | ES2060290T3 (xx) |
GB (1) | GB9001121D0 (xx) |
HK (1) | HK74994A (xx) |
IE (1) | IE67622B1 (xx) |
NZ (1) | NZ236744A (xx) |
ZA (1) | ZA91183B (xx) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
US5407957A (en) * | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
GB9111900D0 (en) * | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
GB9112052D0 (en) * | 1991-06-05 | 1991-07-24 | Efamol Holdings | Fatty acid treatment |
BR9305932A (pt) * | 1992-02-19 | 1997-08-26 | Colby Corp Ltd | Processo para enfrentar e proporcionar resistência a eczema à intoxicação por micotoxina e à sindrome de definharnento de alces em animais processo para tratamento de eczerna de intoxicação por micotoxina e de doença de definnarnento de alces em animais composição de consistência fluida ou pastosa bolo para emprego no tratamento de eczema intoxicação por micotoxina e de sindrome de definhamento de alces composição e processo para tratamento de disturbios que reagem à administração de zinco e composição |
US20050027004A1 (en) * | 1993-06-09 | 2005-02-03 | Martek Biosciences Corporation | Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions |
GB9403855D0 (en) * | 1994-03-01 | 1994-04-20 | Scotia Holdings Plc | Fatty acid derivatives |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
WO1997044026A1 (en) * | 1996-05-22 | 1997-11-27 | Neuromedica, Inc. | Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere |
SK285210B6 (sk) * | 1996-10-11 | 2006-09-07 | Scarista Limited | Farmaceutický prípravok na liečenie schizofrénie a použitie oleja obsahujúceho kyselinu eikozapentaenovú alebo stearidonovú, alebo ich kombináciu na prípravu tohto liečiva |
WO1998048788A1 (en) * | 1997-04-29 | 1998-11-05 | Scotia Holdings Plc | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants |
US6197764B1 (en) | 1997-11-26 | 2001-03-06 | Protarga, Inc. | Clozapine compositions and uses thereof |
US6225444B1 (en) | 1998-02-10 | 2001-05-01 | Protarga, Inc. | Neuroprotective peptides and uses thereof |
FR2774596B1 (fr) * | 1998-02-11 | 2000-03-17 | Rhone Poulenc Rorer Sa | Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer |
US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
US7112609B2 (en) * | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
US6258846B1 (en) * | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
FR2816211B1 (fr) * | 2000-11-08 | 2005-04-01 | Brif | Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses |
EP1427407A4 (en) * | 2001-03-23 | 2005-05-11 | Luitpold Pharm Inc | CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS |
JP4634694B2 (ja) * | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
US20040076695A1 (en) | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
DE10305138A1 (de) * | 2003-02-07 | 2004-08-26 | Axxima Pharmaceuticals Ag | Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen |
US20060292217A1 (en) * | 2005-06-03 | 2006-12-28 | Schmidt Robbin D | Nutritional supplement and soft gelatin capsule delivery system |
NZ540958A (en) * | 2005-06-27 | 2007-11-30 | Agres Ltd | Veterinary formulation for injectable administration of selenomethionine for production of selenium-rich foods |
US8871715B2 (en) * | 2005-10-14 | 2014-10-28 | Alltech, Inc. | Use of selenium compounds, especially selenium yeasts for altering cognitive function |
CN102764279B (zh) * | 2005-10-14 | 2015-04-01 | 全面技术公司 | 改变细胞功能的方法和组合物 |
US20080004255A1 (en) * | 2005-10-14 | 2008-01-03 | Alltech, Inc. | Methods and compositions for altering cell function |
US8865763B2 (en) * | 2005-10-14 | 2014-10-21 | Alltech, Inc. | Methods and compositions for altering cell function |
US20100247679A1 (en) * | 2006-04-24 | 2010-09-30 | Alltech, Inc. | Methods and compositions for altering cell function |
US20100010088A1 (en) * | 2007-11-01 | 2010-01-14 | Wake Forest University School Of Medicine | Compositions and Methods for Prevention and Treatment of Mammalian Diseases |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
WO2009133586A1 (ja) * | 2008-04-28 | 2009-11-05 | 有限会社アンティアンティ | アルツハイマー病の治療医薬 |
AU2011315532B2 (en) * | 2010-10-12 | 2015-02-05 | Vifor Sa | Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US20120252888A1 (en) * | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
JP2016023163A (ja) * | 2014-07-22 | 2016-02-08 | 出光興産株式会社 | γ−リノレン酸を含む神経細胞の酸化ストレス軽減剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1082624A (en) | 1965-02-26 | 1967-09-06 | Calmic Ltd | Improvements in or relating to therapeutically active compounds |
US4273763A (en) * | 1978-01-23 | 1981-06-16 | Efamol Limited | Pharmaceutical and dietary compositions |
IE47777B1 (en) | 1978-01-23 | 1984-06-13 | Efamol Ltd | Pharmaceutical and dietary composition comprising gamma-linolenic acids |
HU204199B (en) * | 1987-03-18 | 1991-12-30 | Caola Kozmetikai | Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components |
EP0298179B1 (fr) * | 1987-07-09 | 1992-04-15 | MOREAU, Pierre | Nouvelles compositions riches en oligoéléments et leurs procédés de fabrication |
-
1990
- 1990-01-18 GB GB909001121A patent/GB9001121D0/en active Pending
-
1991
- 1991-01-08 IE IE5091A patent/IE67622B1/en not_active IP Right Cessation
- 1991-01-09 ZA ZA91183A patent/ZA91183B/xx unknown
- 1991-01-09 CA CA002033823A patent/CA2033823C/en not_active Expired - Fee Related
- 1991-01-09 US US07/638,998 patent/US5116624A/en not_active Expired - Lifetime
- 1991-01-10 AU AU69256/91A patent/AU638525B2/en not_active Ceased
- 1991-01-11 NZ NZ236744A patent/NZ236744A/xx unknown
- 1991-01-14 AT AT91300234T patent/ATE98125T1/de not_active IP Right Cessation
- 1991-01-14 DE DE91300234T patent/DE69100724T2/de not_active Expired - Fee Related
- 1991-01-14 ES ES91300234T patent/ES2060290T3/es not_active Expired - Lifetime
- 1991-01-14 DK DK91300234.1T patent/DK0440341T3/da active
- 1991-01-14 EP EP91300234A patent/EP0440341B1/en not_active Expired - Lifetime
- 1991-01-17 JP JP3003937A patent/JP3008213B2/ja not_active Expired - Fee Related
-
1994
- 1994-07-28 HK HK74994A patent/HK74994A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3008213B2 (ja) | 2000-02-14 |
EP0440341B1 (en) | 1993-12-08 |
ES2060290T3 (es) | 1994-11-16 |
EP0440341A1 (en) | 1991-08-07 |
IE910050A1 (en) | 1991-07-31 |
ATE98125T1 (de) | 1993-12-15 |
AU6925691A (en) | 1991-07-25 |
ZA91183B (en) | 1991-10-30 |
DK0440341T3 (da) | 1994-02-14 |
CA2033823C (en) | 2002-04-09 |
GB9001121D0 (en) | 1990-03-21 |
AU638525B2 (en) | 1993-07-01 |
DE69100724D1 (de) | 1994-01-20 |
IE67622B1 (en) | 1996-04-17 |
NZ236744A (en) | 1993-03-26 |
CA2033823A1 (en) | 1991-07-19 |
JPH0733655A (ja) | 1995-02-03 |
US5116624A (en) | 1992-05-26 |
DE69100724T2 (de) | 1994-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK74994A (en) | EFA compositions and therapy | |
ZA908817B (en) | Stable oral composition of zinc | |
AU8343391A (en) | Hair treatment composition | |
AU2206188A (en) | Azithromycin and derivatives as antiprotozoal agents | |
EP0334507A3 (en) | Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid | |
ZA884484B (en) | Essential fatty acid compositions | |
ES8604417A1 (es) | Procedimiento para la obtencion de una composicion para la higiene bucal a base de aspartato | |
HUT60318A (en) | Compositions comprising isothiazolone derivative stabilized with phenoxyalkanol and process for producing and applying them | |
ES2037073T3 (es) | Un producto para el cuidado de la boca. | |
AU3030192A (en) | Lip treatment composition | |
AU553269B2 (en) | 2,3-diaryl-5-halo thiophenes | |
ZA929879B (en) | Compositions for the treatment of mammalian diseases. | |
ZA857721B (en) | Process for treatment of rheumatic diseases | |
IN172911B (xx) | ||
EP0333490A3 (en) | Composition for the treatment of hepatopathy composition for the treatment of hepatopathy | |
AU1181592A (en) | Oral compositions containing bromochlorophene and zinc ions | |
ZA901320B (en) | Compositions for the treatment of microbial infections | |
GB9022298D0 (en) | Treatment composition | |
GB9113038D0 (en) | Novel treatment and compositions | |
GB9113011D0 (en) | Novel treatment and compositions | |
GB9113039D0 (en) | Novel treatment and compositions | |
GB9113042D0 (en) | Novel treatment and compositions | |
AU6640390A (en) | Vitamin C-zinc treatment methods and compositions | |
IE871913L (en) | 1,3-propanediamine derivatives | |
GB8720753D0 (en) | Composition & treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20060114 |